PMID: 42294340

The role of NAD + metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities.

Ma Zhennan, Gong Xiuqing, Liu Fuquan

Frontiers in oncology · 2026

Vol. 16, pp. 1784749

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.